{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:46:36Z","timestamp":1793126796385,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019266","name":"GlaxoSmithKline Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaip.2025.04.036","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:03:40Z","timestamp":1745982220000},"page":"1816-1823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma"],"prefix":"10.1016","volume":"13","author":[{"given":"John","family":"Busby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Berrar-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabelle","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Gr\u00e1inne d'Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paddy","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharron","family":"Gilbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Kerley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukeshi","family":"Makhecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Louise","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujan H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitasha","family":"Rupani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.04.036_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/thoraxjnl-2011-200257","article-title":"Non-adherence in difficult asthma: time to take it seriously","volume":"67","author":"Heaney","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.04.036_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/thoraxjnl-2011-201096","article-title":"The relationship between clinical outcomes and medication adherence in difficult-to-control asthma","volume":"67","author":"Murphy","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.04.036_bib3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1398-9995.2008.01877.x","article-title":"Adherence rate to inhaled corticosteroids and their impact on asthma control","volume":"64","author":"Lasmar","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.04.036_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.200902-0166OC","article-title":"The prevalence of nonadherence in difficult asthma","volume":"180","author":"Gamble","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/17476348.2013.842129","article-title":"Non-adherence in difficult asthma and advances in detection","volume":"7","author":"Lindsay","year":"2013","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjopharm.2012.04.002","article-title":"Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population","volume":"10","author":"Simoni-Wastila","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jaip.2025.04.036_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thx.2009.113662","article-title":"Adherence to inhaled therapy, mortality and hospital admission in COPD","volume":"64","author":"Vestbo","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.04.036_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201204-0587OC","article-title":"The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma","volume":"186","author":"McNicholl","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib10","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jaip.2022.07.016","article-title":"Assessment of real-world escalation to biologics in US patients with asthma","volume":"10","author":"Bender","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.036_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02259-2019","article-title":"Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma","volume":"55","author":"d'Ancona","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.04.036_bib12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jaip.2017.07.034","article-title":"Trends in omalizumab utilization for asthma: evidence of suboptimal patient selection","volume":"6","author":"Jeffery","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.036_bib13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaip.2020.10.059","article-title":"Clinical outcomes in people with difficult-to-control asthma using electronic monitoring to support medication adherence","volume":"9","author":"Boddy","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.036_bib14","doi-asserted-by":"crossref","first-page":"00273","DOI":"10.1183\/23120541.00273-2021","article-title":"Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy","volume":"7","author":"Butler","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.04.036_bib15","doi-asserted-by":"crossref","first-page":"00123","DOI":"10.1183\/23120541.00123-2019","article-title":"Suppression of Feno with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?","volume":"5","author":"Faruqi","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.04.036_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/thoraxjnl-2020-215168","article-title":"Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era","volume":"76","author":"Jackson","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.04.036_bib17","series-title":"Tezepelumab for treating severe asthma: Technology appraisal guidance (TA880)","year":"2023"},{"key":"10.1016\/j.jaip.2025.04.036_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01168-2024","article-title":"Stepping down biologics in asthma: is it time to challenge the status quo?","volume":"64","author":"Khurana","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.04.036_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41533-024-00365-y","article-title":"Mixed-methods evaluation of an enhanced asthma biologics clinical pathway in the West Midlands UK","volume":"34","author":"Damery","year":"2024","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0042-1743290","article-title":"FeNO in Asthma","volume":"43","author":"Loewenthal","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.04.036_bib22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaip.2022.11.043","article-title":"Baseline FeNO independently predicts the dupilumab response in patients with moderate-to-severe asthma","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.036_bib23","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jaip.2023.03.008","article-title":"Cost-effectiveness of fractional exhaled nitric oxide suppression testing as an adherence screening tool among patients with difficult-to-control asthma","volume":"11","author":"Barry","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.036_bib24","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1378\/chest.130.1_suppl.65S","article-title":"Compliance, adherence, and concordance\u2014Implications for asthma treatment","volume":"130","author":"Horne","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.04.036_bib25","article-title":"Interventions for enhancing medication adherence","volume":"2014","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2025.04.036_bib26","article-title":"Digital interventions to improve adherence to maintenance medication in asthma","volume":"6","author":"Chan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2025.04.036_bib27","article-title":"Improving adherence in chronic airways disease: are we doing it wrongly?","volume":"17","author":"d'Ancona","year":"2021","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.jaip.2025.04.036_bib28","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/all.14737","article-title":"Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma","volume":"76","author":"d'Ancona","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.04.036_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01108-2017","article-title":"Phase three studies of biologics for severe asthma: could do better?","volume":"50","author":"Robinson","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.04.036_bib30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825003940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825003940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:41:35Z","timestamp":1755650495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825003940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213219825003940"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.04.036","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}